-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- Demonstrating Progress: Building a More Equitable Global R&D System in Work In Progress
- This Week in PLOS NTD and PLOS Pathogens: Plant-Virus Ecology; a Genomic Strategy Against P. falciparum; Protective Sand Fly Saliva Proteins; and More in Work In Progress
- Violence Against Women: Implications for our communities, our world and our future in Work In Progress
- University of Geneva hosts Citizen Cyberscience in Work In Progress
- Toms River: A New Classic in Epidemiology Writing in Work In Progress
You may also be interested in:

Click to go to this PLOS Medicine collection
Monthly Archives: November 2011
Protons, Electrons, and Hepatitis C
Category: Drug Development, Hepatitis C
Tagged boceprevir, cyclophilin antagonists, David Goldstein, David Thomas, Egypt, ELECTRON, FISSION, HCV, HCV genotypes, hepatitis C, Ian Lipkin, Ira Jacobson, nonnucleoside polymerase inhibitors, nucleoside polymerase inhibitors, Oliver Pybus, Pharmasset, POSITRON, protease inhibitors, PROTON, PSI-1977, telaprevir
2 Comments


Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.